Gene · 701
Papers3,969
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,969
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bioinformatics analysis of immune infiltration and cell cycle hub genes in atopic dermatitis. | Biochem Biophys Rep | 2025 | 40989718 | PubTator, text mining | PubMed |
| The BUB1 and BUBR1 paralogs scaffold the kinetochore fibrous corona. | Sci Adv | 2025 | 40938979 | PubTator, text mining | PubMed |
| BUB1B promotes homologous recombination‑mediated DNA damage repair in breast cancer cells through the PI3K/AKT signaling pathway. | Oncol Rep | 2025 | 40910254 | PubTator, text mining | PubMed |
| Shared transcriptional regulators and network rewiring identify therapeutic targets linking type 2 diabetes mellitus and hypertension. | Front Mol Biosci | 2025 | 40909129 | PubTator, text mining | PubMed |
| Maternal uniparental disomy of chromosome 15 with concurrent paternal non-chromosome 15 marker chromosome: a rare presentation of prader-willi syndrome. | Mol Cytogenet | 2025 | 40883760 | PubTator, text mining | PubMed |
| MRE11 orchestrates porcine oocyte meiotic progression by modulating the spindle assembly checkpoint. | Front Cell Dev Biol | 2025 | 40861270 | PubTator, text mining | PubMed |
| KIFC1 Overexpression Promotes Pancreatic Carcinoma Progression via Stabilising BUB1B. | J Cell Mol Med | 2025 | 40857057 | PubTator, text mining | PubMed |
| Targeting receptor for activated C kinase 1 with a small molecule induces mitotic catastrophe and suppresses lipid metabolic reprogramming in hepatocellular carcinoma. | Clin Transl Med | 2025 | 40836602 | PubTator, text mining | PubMed |
| Multi-Omics analysis and in vitro validation reveal diagnostic and therapeutic roles of novel hub genes in ovarian cancer. | Hereditas | 2025 | 40826138 | PubTator, text mining | PubMed |
| CENcyclopedia: dynamic landscape of kinetochore architecture throughout the cell cycle. | Nat Commun | 2025 | 40825761 | PubTator, text mining | PubMed |
| Mitochondrial fission genes MTFP1/MTFP2 as predictive biomarkers in prostate cancer: a mendelian randomization study. | Discov Oncol | 2025 | 40824549 | PubTator, text mining | PubMed |
| High-throughput virtual screening, identification and in vitro biological evaluation of novel inhibitors of PLK1 and NRP1. | J Enzyme Inhib Med Chem | 2025 | 40820676 | PubTator, text mining | PubMed |
| BUB1B promotes gemcitabine resistance in lung adenocarcinoma and activates the PI3K/AKT signaling pathway. | Am J Med Sci | 2025 | 40812730 | PubTator, text mining | PubMed |
| 3D Tumor microenvironment interaction reveals AP-1 complex regulation and contact-mediated reprogramming of bone marrow stromal cells in chronic lymphocytic leukemia. | Hemasphere | 2025 | 40809351 | PubTator, text mining | PubMed |
| A prospective cohort study to develop multi-biomarkers panel to define biological ageing in six different cohorts from newborn to oldest adult: a study protocol. | Biol Methods Protoc | 2025 | 40799309 | PubTator, text mining | PubMed |
| Bioinformatics analysis to identify endocrine-disrupting chemicals targeting key ESCC-related genes. | Toxicol Mech Methods | 2025 | 40761015 | PubTator, text mining | PubMed |
| Methionine Deprivation-induced Cancer Cell Death and Methylation Changes in Key Genes and Gene Promoters of Prostate Cancer Cell Lines. | Anticancer Res | 2025 | 40750410 | PubTator, text mining | PubMed |
| High glucose-induced mitochondrial fission drives pancreatic cancer progression through the H3K18la/TTK/BUB1B signal pathway. | Cell Signal | 2025 | 40744332 | PubTator, text mining | PubMed |
| Significant prognostic value of cell-cycle proteins in early-stage small cell carcinoma of cervix. | Sci Rep | 2025 | 40702150 | PubTator, text mining | PubMed |
| High-throughput screening identifies a previously undescribed checkpoint controlling mitotic progression in response to DNA damage. | FEBS J | 2025 | 40641039 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/701/papers?page=6